Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

Goiter

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

The Thyroid Gland

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pendred syndrome.

Expert review of endocrinology & metabolism·2018

Same author

[Clinical and molecular study of five families with resistance to thyroid hormones].

Medicina clinica·2011

See all related articles

Search research articles

Related Experiment Video

Updated: May 18, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Genetic bases of benign thyroid processes.

Joaquín Lado Abeal¹, Lourdes Domínguez Gerpe

¹Unidade de Enfermedades Tiroideas e Metabólicas (UETeM). Departamento de Medicina. Universidad de Santiago de Compostela. Santiago de Compostela. A Coruña. España.

Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion

|September 13, 2012

Summary

This summary is machine-generated.

Advances in gene analysis have identified genetic causes for thyroid diseases, including new syndromes and toxic goiters. Research continues to uncover the genetic basis of other thyroid conditions, promising future discoveries.

More Related Videos

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Related Experiment Videos

Last Updated: May 18, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Area of Science:

Genetics
Endocrinology
Molecular Biology

Background:

Gene analysis techniques have advanced significantly, simplifying the study of disease genetics.
Genome sequencing is becoming faster and more affordable.
Understanding the genetic basis of thyroid diseases is crucial for diagnosis and treatment.

Purpose of the Study:

To review the current understanding of genetic bases in thyroid diseases.
To highlight recent discoveries in thyroid hormone action, transport, and metabolism defects.
To identify remaining challenges and future research directions in benign thyroid disorders.

Main Methods:

Literature review of recent advances in gene analysis and sequencing.
Analysis of identified genes related to thyroid hormone formation, action, transport, and metabolism.
Identification of genetic factors in toxic adenomas, multinodular goiters, and follicular thyroid adenomas.

Main Results:

Genetic bases for defects in thyroid hormone formation are well-defined.
Genes for two new syndromes (MCT8 and SECISBP2 mutations) affecting thyroid hormone action have been discovered.
Genetic bases for toxic adenomas and multinodular goiters are determined; several genes for follicular thyroid adenomas identified.

Conclusions:

Significant progress has been made in identifying genes for thyroid diseases, particularly toxic conditions.
The genetic bases for multinodular hyperplastic goiter and most autoimmune thyroid disorders remain largely unknown.
Future research holds promise for characterizing the genetic underpinnings of benign thyroid processes due to technological advancements and disease prevalence.